Sattva Sukun Lifecare Share Price Today

Tavexia Lifecare Q2FY27 Results: Consolidated loss of ₹56 lakh, RTA change approved

Consolidated loss of ₹56.13 lakh for H1FY27 vs profit of ₹131.55 lakh in H1FY26. Consolidated revenue declined to ₹568.39 lakh from ₹1,805.88 lakh YoY. Board approved change of RTA from Niche Technologies to Skyline Financial Services. Proposed raising of ₹68 crore to fund acquisition of 60% stake in Meyonex Pharmaceuticals.

Tavexia Lifecare acquires 60% stake in Meyonex for ₹67.19 crore

Tavexia Lifecare acquires 60% stake in Meyonex Pharmaceuticals for ₹67.19 crore. Acquisition executed via cash subscription of fresh equity shares at ₹32 per share. Company rebranded from Sattva Sukun Lifecare to focus on APIs, CDMO, and nutraceuticals. Meyonex reported turnover decline from ₹13.32 crore in FY24 to ₹10.79 crore in FY25.

Tavexia Lifecare passes all four resolutions at 46th AGM

Tavexia Lifecare passed all four resolutions at its 46th AGM. Special resolution approved material related party transactions up to ₹100 crore. Promoter votes of 15,460,794 were invalidated for the RPT resolution due to interest conflict. Mrs. Khushboo Vasudev re-appointed as independent director for a second five-year term.

Tavexia Lifecare board to decide on Meyonex acquisition on Oct 7

Board meeting scheduled for October 7, 2026, to decide on acquiring up to 60% equity in Meyonex Pharmaceuticals. Acquisition proposal initially approved on September 7, 2026, with subsequent due diligence authorized. Trading window closed from September 30, 2026, until 48 hours post-board meeting per SEBI regulations. Target company is Meyonex Pharmaceuticals Limited, an unlisted public entity.

Tavexia promoter sells 2.5 lakh equity shares via open market

Roshan Dealmark Private Limited sold 2,50,000 Tavexia Lifecare shares on September 28, 2026. Promoter group holding decreased from 3.713% to 3.647% following the latest disposal. Total shares sold by the group since September 24 stand at 11,50,000. Puja Agarwal's holding of 80,000 shares remained unchanged during the period.

Sattva Sukun promoters dispose 9.07 lakh shares on-market

Promoters Roshan Dealmark and Puja Agarwal sold 9,07,105 shares on September 21, 2026. Post-sale, promoter group holding reduced to 4.051% from 4.288%. Transaction executed via on-market mechanism; total diluted capital unchanged at 38.36 crore shares.